Reduced intravenous glutathione in the treatment of early Parkinson's disease.

Sechi, G; Deledda, M G; Bua, G; Satta, W M; Deiana, G A; Pes, G M; Rosati, G

Sechi, G; Deledda, M G; Bua, G; Satta, W M; Deiana, G A; Pes, G M; Rosati, G.

Affiliation

Sechi G; Department of Neurology, University of Sassari, Italy.

Prog Neuropsychopharmacol Biol Psychiatry ; 20(7): 1159-70, 1996 Oct.

Article in En | MEDLINE | ID: mdl-8938817

Subject(s)

Glutathione/therapeutic use; Parkinson Disease/drug therapy; Aged; Disease Progression; Female; Glutathione/administration & dosage; Glutathione/adverse effects; Humans; Injections, Intravenous; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease/diagnosis; Tremor/drug therapy

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Parkinson Disease / Glutathione Type of study: Diagnostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Year: 1996 Type: Article

Search on Google

XML

PubMed Links